Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9294647 | 0.87 | ALDH1A1 (0.56) | CYP1A2CYP2C9CYP2C19CYP3A4GAA | |
| SCHEMBL9293375 | 0.83 | CYP1A2 (0.49) | CYP1A2CYP2C9CYP2C19CYP3A4GAA | |
| SCHEMBL9294680 | 0.83 | CA12 (0.56) | CYP1A2CYP2C9CYP2C19CYP3A4GAA | |
| SCHEMBL7753595 | 0.82 | ALDH1A1 (0.44) | CYP1A2CYP2C9CYP2C19CYP3A4GAA | |
| SCHEMBL7755677 | 0.80 | CYP1A2 (0.44) | CYP1A2CYP2C9CYP2C19CYP3A4GAA | |
| SCHEMBL7755689 | 0.80 | CYP1A2 (0.44) | CYP1A2CYP2C9CYP2C19CYP3A4GAA | |
| SCHEMBL9198250 | 0.80 | CYP1A2 (0.45) | CYP1A2CYP2C9CYP2C19CYP3A4GAA | |
| SCHEMBL7754261 | 0.80 | CYP1A2 (0.43) | CYP1A2CYP2C9CYP2C19CYP3A4GAA | |
| SCHEMBL7753627 | 0.80 | CYP1A2 (0.43) | CYP1A2CYP2C9CYP2C19CYP3A4GAA | |
| SCHEMBL7754266 | 0.80 | CYP1A2 (0.43) | CYP1A2CYP2C9CYP2C19CYP3A4GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010029239-A1 | New herbicidal compositions | CRAMP MICHAEL COLIN (GB) | 2001-10-11 | — | — | US | disclosed |
| WO-2001047863-A2 | NEW HERBICIDAL COMPOSITIONS | AVENTIS CROPSCIENCE SA (FR) | 2001-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010029239-A1 | New herbicidal compositions | DDT, CYP1B1, CYP4X1 | CYP1A2 12/4885CYP2C9 38/4885CYP2C19 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.